An interventional study of Multimodal Vaccine Program in HPV Immunization Status, sponsored by University of Colorado, Denver. Completed at 1 site in United States. Open to participants aged 9 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-24.
Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Health services research
The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.
University of Colorado, Denver is the lead sponsor of 1,538 studies on the registry; 318 are open to participants now.
Of its 146 completed or terminated interventional studies of FDA-regulated products, 92 (63%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria for immunization rate assessment:
Exclusion Criteria:
Provider survey:
Providers who are working at participating practices during the two times a cross-sectional survey is administered.
Parent survey:
Parents of adolescents who presented for care within one 1 year prior to the two times a cross-sectional survey is administration.
Intervention offices will adopt a multi-modal vaccine program to increase their patients' vaccine rates.
Behavioral: Multimodal Vaccine Program
Control offices will offer usual health care related to immunizations throughout the duration of the study.
Efforts will be made to collaborate with pediatric and family medicine offices to utilize a multimodal intervention to improve adolescents' HPV immunization rates. As part of the overall intervention, four intervention strategies will be used: 1) a tailored website, iVac -HPV , 2) Motivational Interview Training for providers, 3) HPV Fact Sheets and 4) The Decision Aid for HPV Vaccines
The percentage of adolescents who initiate the HPV vaccine series
The percent of eligible patients presenting for care at intervention offices who receive one or more HPV vaccines (using administrative, Electronic Medical Records (EMR), and Colorado Immunization Information System (CIIS) immunization data), during the intervention year, compared to the percent in control offices.
Time frame: 1 year
The percentage of adolescents who receive MCV4 vaccine
The percent of eligible patients presenting for care at intervention offices who receive MCV4 vaccine (using administrative, EMR and CIIS immunization data) compared to the percent in control offices.
Time frame: 1 year
The percentage of adolescents who receive Tdap vaccine
The percentage of eligible patients presenting for care at intervention offices who receive Tetanus, Diphtheria, Pertussis (Tdap) vaccine (using administrative, EMR and CIIS immunization data) during the intervention year compared to the percent in control offices.
Time frame: 1 year
Provider HPV vaccine recommendations
The change in intervention providers' HPV vaccine communication practices compared to control providers' as measured by self-report prior to the intervention and after the intervention.
Time frame: 1 year
Parents' experiences and preferences regarding provider communication about HPV vaccines
The change in intervention parents' experiences and preferences regarding provider HPV vaccine communication compared to parents of adolescents attending control practices as measured by self report prior to the intervention and after the intervention.
Time frame: 1 year
This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Colorado, Denver →